1. Merritt J et al. Clinical phase I experience with INGN 201 (Ad-p53) in non-small cell lung cancer and head and neck cancer Cancer Gene Ther 1997 4: S12 (Abstr.)
2. Nemunaitis J et al. Three phase II trials of intratumoral injection with a replication-deficient adenovirus carrying the p53 gene (AdCMV-p53) in patients with recurrent/refractory head and neck cancer Proc Am Soc Clin Oncol 1999 18: 1661
3. Kirn D . Replication-selective micro-organisms: fighting cancer with targeted germ warfare J Clin Invest 2000 105: 836–838
4. Heise C, Kirn D . Replication-selective adenviruses as oncolytic agents J Clin Invest 2000 105: 847–851
5. Pawelek J, Low K, Bermudes D . Tumor-targeted Salmonella as a novel anticancer vector Cancer Res 1997 57: 4537–4544